Pathobiology and treatment of viral keratitis

Exp Eye Res. 2021 Apr:205:108483. doi: 10.1016/j.exer.2021.108483. Epub 2021 Feb 6.

Abstract

Keratitis is one of the most prevalent ocular diseases manifested by partial or total loss of vision. Amongst infectious (viz., microbes including bacteria, fungi, amebae, and viruses) and non-infectious (viz., eye trauma, chemical exposure, and ultraviolet exposure, contact lens) risk factors, viral keratitis has been demonstrated as one of the leading causes of corneal opacity. While many viruses have been shown to cause keratitis (such as rhabdoviruses, coxsackieviruses, etc.), herpesviruses are the predominant etiologic agent of viral keratitis. This chapter will summarize current knowledge on the prevalence, diagnosis, and pathobiology of viral keratitis. Virus-mediated immunomodulation of host innate and adaptive immune components is critical for viral persistence, and dysfunctional immune responses may cause destruction of ocular tissues leading to keratitis. Immunosuppressed or immunocompromised individuals may display recurring disease with pronounced severity. Early diagnosis of viral keratitis is beneficial for disease management and response to treatment. Finally, we have discussed current and emerging therapies to treat viral keratitis.

Keywords: Antiviral drugs; Host-virus interaction; Human herpesvirus; Inflammation; Ocular infection; Viral keratitis.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Eye Infections, Viral* / drug therapy
  • Eye Infections, Viral* / pathology
  • Eye Infections, Viral* / virology
  • Humans
  • Keratitis* / drug therapy
  • Keratitis* / pathology
  • Keratitis* / virology
  • Prevalence

Substances

  • Antiviral Agents